| Scientists Create Synthetic Organism Scientists for the first time created a synthetic cell, controlled by man-made genetic instructions, a move that could open the way to the manipulation of life on a new scale. online.wsj.com |
Quest 2Q earnings rise, but outlook pummels shares (AP) Quest Diagnostics reported that second-quarter net income climbed 3 percent, yet the medical laboratory operator cut its annual guidance Wednesday because of falling revenue and shares tumbled 8 percent before the market opened. us.rd.yahoo.com |
FDA Dislikes Novartis on Facebook: Biotech's Latest Mishaps The Burrill Report submits: The U.S. Food and Drug Administration notified Novartis (NVS) that information the drug maker has on Facebook about its cancer drug Tasigna is misleading because it makes claims of its efficacy, but fails to note any risks. The agency also said in a letter to the company that the content inadequately communicates Tasigna’s FDA-approved indication and implies superiority over other products. The FDA noted that Novartis failed to submit the marketing material as required under regulations. Tasigna is indicated for certain forms of chronic myelogenous leukemia in adult patients resistant or intolerant to prior therapy that includes imatinib. The FDA also approved Tasigna for second line treatment of chronic or accelerated phase Ph+ CML. The agency told the company to cease the dissemination of the problematic promotional materials and provide a written response. Cypress Bioscience (CYPB) said it was cutting 123 employees or 86 percent of its workforce as part of an effort to cut operating costs by about $10 million a year. The announcement came as part of broader steps being taken by the company that includes plans to discontinue or sell its personalized medicine services business by the end of the third quarter and discontinuing its rights under its agreement with Forest Laboratories to co-promote Savella, its drug for fibromyalgia. Forest has agreed to pay Cypress a one-time payment of $2.0 million to help facilitate with this transition. Cypress will retain all other rights under its agreement with Forest including its royalty on Savella sales and may pursue the opportunity to re-activate the co-promotion right through discussions with Forest in the future. Forest will maintain promotional levels behind Savella.Complete Story » seekingalpha.com |
RadNet to Present at Deutsche Bank Leveraged Finance Conference [GlobeNewswire] - LOS ANGELES -- RadNet, Inc. , a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 191 fully-owned and operated outpatient imaging centers, today announced that Mark Stolper, executive vice president and chief financial officer, will participate in the Deutsche Bank Leveraged Finance Conference on Thursday, Oct. 7, at The Phoenician in Scottsdale, Ariz. us.rd.yahoo.com |
Alliance Healthcare Services Schedules Conference Call and Webcast to Review Third Quarter 2010 Financial Results [Business Wire] - Alliance HealthCare Services announced today that it will host a conference call and webcast on Thursday, October 28, 2010 at 8:30 a.m. Eastern Time to discuss the Company’s third quarter 2010 financial results, which are scheduled to be released after the market closes on Wednesday, October 27, 2010. us.rd.yahoo.com |